At a glance
ClinicalIndex Comparison RecordN/ACompleted· 471 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Glucose Transporter Type I Deficiency (G1D) Registry
University of Texas Southwestern Medical Center·observational·Posted Dec 17, 2013·Updated Mar 7, 2025
In Brief
An observational study evaluating No intervention for GLUT1 Deficiency Syndrome and 3 related conditions. Completed, enrolled 471 participants across 1 site.
Detailed Summary
The purpose of this protocol is to create a registry for patients diagnosed with Glucose Transporter Type 1 Deficiency (G1D), or patients experiencing symptoms consistent with G1D but not yet diagnosed, to enter medical information for physicians and other health researchers to analyze to increase the understanding of G1D and any sub-diagnoses.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGLUT1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter Type1 (GLUT-1) Deficiency, GLUT-1 Deficiency Syndrome
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartDec 2013
First PostedDec 2013
Primary CompletionAug 2024
TodayJul 2026
First PostedDec 17, 2013
Enrollment StartDec 1, 2013
Primary CompletionAug 1, 2024
TodayJul 2, 2026
Enrollment to primary: 10.7 yearsPosted 12.5 years ago
Interventions
No interventionother
This is an observational registry. No interventions are required or provided.